Shopping Cart
- Remove All
- Your shopping cart is currently empty
BML-260 is a potent dual-specificity inhibitor of the phosphatases JSP-1 and DUSP22. It can activate UCP1 and induce thermogenesis in adipocytes independently of JSP-1. The effects of BML-260 on adipocytes partially occur through the activation of the CREB, STAT3, and PPAR signaling pathways. This compound is useful for research on inflammation, proliferative disorders associated with JNK signaling dysfunction, and obesity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | BML-260 is a potent dual-specificity inhibitor of the phosphatases JSP-1 and DUSP22. It can activate UCP1 and induce thermogenesis in adipocytes independently of JSP-1. The effects of BML-260 on adipocytes partially occur through the activation of the CREB, STAT3, and PPAR signaling pathways. This compound is useful for research on inflammation, proliferative disorders associated with JNK signaling dysfunction, and obesity. |
Molecular Weight | 341.4 |
Formula | C17H11NO3S2 |
Cas No. | 101439-76-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.